Ummino

Ummino is pioneering clinically grounded microbiome solutions for the growing metabolic health market. With roughly 130 million Americans affected by metabolic syndrome and GLP-1 adoption accelerating nationwide, Ummino is positioned at the intersection of gut health and metabolic resilience. Built on over 20 years of microbiome research by career microbiologists Dr. Andrea Azcarate-Peril, Professor of Medicine and Director of the Microbiome Core Facility at UNC-Chapel Hill, and Dr. Jose Bruno-Barcena, tenured Professor of Microbiology at NC State University, Ummino was born when Charles and Jose met over lunch in early 2022.